The John Curtin School of Medical Research will be home to the Australian part of the new centre.
The early identification of 'bio-markers' to aid in the fight against diabetes, depression and other epidemic diseases will be the focus of a new Australian-German centre launched today at The Australian National University. The Australian-German Institute for Translational Medicine (GAITM) is a joint project between the John Curtin School of Medical Research (JCSMR) at ANU and the Technische Universität Dresden. It will be run by JCSMR Director Professor Julio Licinio and Professor Stefan R Bornstein of the Department of Medicine at the Dresden University Hospital. It will work to develop a research and knowledge exchange program between the two countries with the aim of preventing epidemic diseases such as diabetes, depression, high blood pressure and dementia. 'This is a very exciting development in the newly-emerging field of translational medicine,' said Professor Licinio. ?The research the Institute undertakes will work towards new treatment methods using translational medicine. Translational medicine aims to quickly translate new developments in science to the patient by combining research findings from the laboratory and traditional clinical research leading to a quicker development of new diagnostic procedures, drugs or therapies. 'We're delighted to partner with the Technische Universität Dresden in this important endeavour. Both universities are pioneering the academic roll out of translational medicine, and both bring vast amounts of experience and expertise to the Institute,?
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
